Michigan medtech company raises $77M for renal denervation solution to hypertension

MedCity News | January 04, 2019

Hypertension is a condition that affects millions of people around the world and can lead to serious health issues including cardiac arrest, stroke and heart failure. It also represents a significant burden and cost to the healthcare system as a whole. One potential innovative pathway to addressing hypertension outside of traditional medication is through a process known as renal denervation, where nerves in the renal system are targeted to reduce blood pressure.

Spotlight

"I can't afford to call out sick for the shift that is life. I take time for my annual check-up, because self-care is health care."


Other News

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More